NasdaqGS - Nasdaq Real Time Price USD

Design Therapeutics, Inc. (DSGN)

3.5000
-0.0200
(-0.57%)
At close: May 9 at 4:00:02 PM EDT
3.5000
0.00
(0.00%)
After hours: May 9 at 5:53:48 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
62,383
62,383
78,190
67,593
35,831
Operating Income
-62,383
-62,383
-78,190
-67,593
-35,831
Net Non Operating Interest Income Expense
12,795
12,795
11,328
--
--
Other Income Expense
2,295
--
11,328
4,285
298
Pretax Income
-49,588
-49,588
-66,862
-63,308
-35,533
Net Income Common Stockholders
-49,588
-49,588
-66,862
-63,308
-35,533
Diluted NI Available to Com Stockholders
-49,588
-49,588
-66,862
-63,308
-35,533
Basic EPS
-0.88
--
-1.19
-1.14
-0.77
Diluted EPS
-0.88
--
-1.19
-1.14
-0.77
Basic Average Shares
56,587.1420
--
55,984.6700
55,707.5170
45,936.2350
Diluted Average Shares
56,587.1420
--
55,984.6700
55,707.5170
45,936.2350
Total Operating Income as Reported
-62,383
-62,383
-78,190
-67,593
-35,831
Total Expenses
62,383
62,383
78,190
67,593
35,831
Net Income from Continuing & Discontinued Operation
-49,588
-49,588
-66,862
-63,308
-35,533
Normalized Income
-49,588
-49,588
-66,862
-63,308
-35,533
Interest Income
12,795
12,795
11,328
--
--
Net Interest Income
12,795
12,795
11,328
--
--
EBIT
-62,383
-62,383
-78,190
-67,593
-35,831
EBITDA
-61,787
-61,787
-77,653
-67,187
-35,702
Reconciled Depreciation
596
596
537
406
129
Net Income from Continuing Operation Net Minority Interest
-49,588
-49,588
-66,862
-63,308
-35,533
Normalized EBITDA
-61,787
-61,787
-77,653
-67,187
-35,702
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 3/29/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CGEM Cullinan Therapeutics, Inc.
7.54
-2.96%
 
IKNA Ikena Oncology, Inc.
1.1300
+4.63%
 
ORIC ORIC Pharmaceuticals, Inc.
5.08
-4.51%
 
ANAB AnaptysBio, Inc.
19.59
+0.05%
 
PMVP PMV Pharmaceuticals, Inc.
0.8827
-0.12%
 
GLUE Monte Rosa Therapeutics, Inc.
4.0900
-3.08%
 
EWTX Edgewise Therapeutics, Inc.
14.58
-0.82%
 
ACRS Aclaris Therapeutics, Inc.
1.2600
-3.82%
 
VTYX Ventyx Biosciences, Inc.
1.2400
+5.98%
 
BOLD Boundless Bio, Inc.
1.4400
-4.00%